[No authors listed]
BACKGROUND:Recent studies indicated that Derlin-1 has an important function in cancer progression. However, its expression pattern and relationships with clinicopathologic characteristics in non-small cell lung cancer (NSCLC) have not been completely found. In the current study, we aimed to evaluate the prognostic significance of Derlin-1 in NSCLC. METHODS:Cancer tissues and paracancer tissues were collected from 168 patients with NSCLC. The expression of Derlin-1 was detected by RT-PCR, Western blot, and immunohistochemistry. The correlation between Derlin-1 expression and various clinicopathologic features was investigated. RESULTS:The results showed that mRNA and protein of Derlin-1 was overexpressed in NSCLC and the positive rate of Derlin-1 was significantly correlated with TNM stage, histologic grade, lymph node metastasis and overall survival. CONCLUSION:Derlin-1 is overexpressed in NSCLC and promotes the malignancy of NSCLC. Derlin-1 maybe served as a potential therapeutic target for NSCLC.
KEYWORDS: {{ getKeywords(articleDetailText.words) }}
Sample name | Organism | Experiment title | Sample type | Library instrument | Attributes | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
{{attr}} | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
{{ dataList.sampleTitle }} | {{ dataList.organism }} | {{ dataList.expermentTitle }} | {{ dataList.sampleType }} | {{ dataList.libraryInstrument }} | {{ showAttributeName(index,attr,dataList.attributes) }} |
{{ list.authorName }} {{ list.authorName }} |